Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Praluent Pricing: Collaboration With ICER Sets A New Standard

Mar 12 2018

• By Jessica Merrill

Hands

Related Content

Sanofi, Regeneron Setting 'New Paradigm' With Dupixent Pricing In US?

Apr 04 2017

Amgen Says Repatha Outcomes Trial Backs Up Its Pricing Math

Mar 20 2017

Repatha Pricing Pressure Might Actually Increase After Outcomes Trial

Jun 15 2017

PCSK9 Sales Still Slow, But May Get Boost From Label, Guideline Changes

Aug 05 2017

The Price Is Right: Amgen Defends Repatha At $9,669 Against More Critics

Aug 23 2017

PCSK9 Turning Point? Sanofi/Regeneron Dangle Lower Price Carrot For Praluent

Mar 13 2018

Related Companies

Sanofi

Regeneron Pharmaceuticals, Inc.

Amgen, Inc.

Express Scripts Holding Company

Additional Topics

United States Pricing Debate Pricing Strategies Reimbursement Commercial Cardiovascular BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window